After stimulating myeloid blood cells with R848, we observed that multiple myeloid subsets from COVID-19 patients had lower levels of IFNβ and higher levels of TNF, IL-6, IL-12, CCL3, and CCL4 than cells from healthy controls (Fig. 5d). This evidence concerns the gene IFNB1 and COVID-19.